MML Investors Services’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$718K Buy
42,854
+6,377
+17% +$107K ﹤0.01% 1861
2025
Q1
$561K Buy
36,477
+388
+1% +$5.97K ﹤0.01% 1916
2024
Q4
$795K Sell
36,089
-440
-1% -$9.69K ﹤0.01% 1648
2024
Q3
$658K Sell
36,529
-5,710
-14% -$103K ﹤0.01% 1697
2024
Q2
$686K Sell
42,239
-795
-2% -$12.9K ﹤0.01% 1600
2024
Q1
$607K Buy
43,034
+3,115
+8% +$43.9K ﹤0.01% 1695
2023
Q4
$417K Buy
39,919
+4,254
+12% +$44.4K ﹤0.01% 1857
2023
Q3
$364K Sell
35,665
-848
-2% -$8.66K ﹤0.01% 1814
2023
Q2
$275K Buy
36,513
+6,006
+20% +$45.2K ﹤0.01% 1982
2023
Q1
$270K Sell
30,507
-1,354
-4% -$12K ﹤0.01% 1739
2022
Q4
$291K Sell
31,861
-1,381
-4% -$12.6K ﹤0.01% 1798
2022
Q3
$268K Buy
33,242
+1,536
+5% +$12.4K ﹤0.01% 1753
2022
Q2
$238K Sell
31,706
-3,615
-10% -$27.1K ﹤0.01% 1809
2022
Q1
$332K Sell
35,321
-1,475
-4% -$13.9K ﹤0.01% 1660
2021
Q4
$295K Sell
36,796
-4,481
-11% -$35.9K ﹤0.01% 1711
2021
Q3
$402K Buy
41,277
+7,564
+22% +$73.7K ﹤0.01% 1471
2021
Q2
$334K Sell
33,713
-15,976
-32% -$158K ﹤0.01% 1546
2021
Q1
$573K Sell
49,689
-4,929
-9% -$56.8K 0.01% 1196
2020
Q4
$527K Sell
54,618
-13,984
-20% -$135K 0.01% 1132
2020
Q3
$618K Sell
68,602
-11,585
-14% -$104K 0.01% 948
2020
Q2
$989K Sell
80,187
-5,935
-7% -$73.2K 0.01% 716
2020
Q1
$773K Buy
86,122
+1,911
+2% +$17.2K 0.01% 697
2019
Q4
$825K Sell
84,211
-4,087
-5% -$40K 0.01% 793
2019
Q3
$607K Sell
88,298
-24,240
-22% -$167K 0.01% 874
2019
Q2
$1.04M Sell
112,538
-8,139
-7% -$75.1K 0.01% 705
2019
Q1
$1.89M Buy
120,677
+621
+0.5% +$9.74K 0.03% 480
2018
Q4
$1.85M Sell
120,056
-3,804
-3% -$58.6K 0.03% 440
2018
Q3
$2.67M Buy
123,860
+30,163
+32% +$650K 0.05% 359
2018
Q2
$2.28M Sell
93,697
-1,244
-1% -$30.3K 0.05% 324
2018
Q1
$1.62M Sell
94,941
-9,576
-9% -$164K 0.03% 400
2017
Q4
$1.98M Buy
104,517
+12,671
+14% +$240K 0.04% 356
2017
Q3
$1.62M Buy
91,846
+58,191
+173% +$1.02M 0.03% 387
2017
Q2
$1.12M Buy
33,655
+3,236
+11% +$107K 0.02% 474
2017
Q1
$976K Buy
+30,419
New +$976K 0.02% 282